|
| |
Recent News |
|
|
|
|
|
October 25, 2008 |
|
|
October 21, 2008 |
|
|
September 20, 2008 |
|
|
June 10, 2008 |
|
|
May 23, 2008 |
|
|
April 24, 2008 |
|
|
January 31, 2008 |
|
|
January 16, 2008 |
|
|
December 1, 2007 |
|
|
November 15, 2007 |
|
|
|
|
|
|
If you would like to subscribe for our newsletter, please enter your email here |
|
|
|
|
Created by: AeroWeb
Boston Web Design - Web Hosting
|
|
 |
Company mission:
Cure Lab is a biotechnology company committed to the development of effective vaccines against infectious diseases and cancer. |
| |
|
|
 |
|
Company focus:
Cure Lab is intensively focusing on development of vaccines against influenza due to the threat of an impending pandemic.
The first in the pipeline of Cure Lab's anti-influenza T-cell vaccines (CLVax 1.0) has demonstrated protection
against a wide variety of both mammalian and avian influenza (flu) strains when tested in rodent and chicken models.
Cure Lab, Inc. is a private biotechnology company founded in 2002. |
|
|
|
|
|
|
Cure Lab, Inc. 216 Bolivar Street Canton, MA 02021
| Tel: 877-778-1753 |
|
|
|
